CG Oncology, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -48.55M-88.04M
Share-based Compensation 1.53M11.40M
Gains from Investment Securities 0.22M
Non-cash Items 40.29M108.16M
Cash from Operations -45.68M-78.71M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 2.88M4.99M
Depreciation & Amortization (CF) 0.02M0.03M
Change in Working Capital
Change in Receivables 0.69M
Change in Account Payables 2.01M3.27M
Change in Accured Expenses 4.14M5.47M
Investing Activities
Capital Expenditures 0.23M
Change in Acquisitions & Divestments 396.42M745.41M
Cash from Investing Activities -121.19M-300.76M
Financing Activities
Other financing activities -3.42M-3.42M
Change in Capital Stock
Shares Issued 2.08M406.41M
Preferred Shares Issued 104.63M
Misc.
Cash from Financing Activities 87.00M628.28M
Change in Cash -79.88M248.80M
Free Cash Flow -45.68M-78.95M
Net Cash Flow -79.88M248.80M